Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian B McDermott

Showing results (41-50 of 179) with videos related to

Pageof 18
Sort By:
Clinical Pharmacology and Therapeutics|September 1, 2020
Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics ApproachJerry Li, Mina Nikanjam, Coleen K Cunningham, et al.
Journal of Virology|November 27, 2004
A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variationDavid H O'Connor, Adrian B McDermott, Kendall C Krebs, et al.
Vaccine|May 22, 2021
A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluationKrishana Gulla, Nicole Cibelli, Jonathan W Cooper, et al.
Plos One|November 16, 2016
Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)Michelle C Crank, Eleanor M P Wilson, Laura Novik, et al.
Cell Host & Microbe|July 4, 2020
Convergent Evolution in Breadth of Two V<sub>H</sub>6-1-Encoded Influenza Antibody Clonotypes from a Single DonorNicholas C Wu, Sarah F Andrews, Julie E Raab, et al.
Journal of Virology|November 25, 2005
Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaquesAdrian B McDermott, David H O'Connor, Sarah Fuenger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2015
H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin StemAdam K Wheatley, James R R Whittle, Daniel Lingwood, et al.
Medrxiv : the Preprint Server for Health Sciences|January 14, 2021
Fever, Diarrhea, and Severe Disease Correlate with High Persistent Antibody Levels against SARS-CoV-2Maya F Amjadi, Sarah E O'Connell, Tammy Armbrust, et al.
Immunity|March 1, 2025
Early influenza virus exposure shapes the B cell response to influenza vaccination in individuals 50 years laterAbby Spangler, Geoffrey D Shimberg, Grace E Mantus, et al.
Frontiers in Immunology|June 14, 2024
Anti-idiotype isolation of a broad and potent influenza A virus-neutralizing human antibodyAdam S Olia, Madhu Prabhakaran, Darcy R Harris, et al.
Pageof 18

Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
Clinical Pharmacology and Therapeutics|September 1, 2020
Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics ApproachJerry Li, Mina Nikanjam, Coleen K Cunningham, et al.
Journal of Virology|November 27, 2004
A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variationDavid H O'Connor, Adrian B McDermott, Kendall C Krebs, et al.
Vaccine|May 22, 2021
A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluationKrishana Gulla, Nicole Cibelli, Jonathan W Cooper, et al.
Plos One|November 16, 2016
Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)Michelle C Crank, Eleanor M P Wilson, Laura Novik, et al.
Cell Host & Microbe|July 4, 2020
Convergent Evolution in Breadth of Two V<sub>H</sub>6-1-Encoded Influenza Antibody Clonotypes from a Single DonorNicholas C Wu, Sarah F Andrews, Julie E Raab, et al.
Journal of Virology|November 25, 2005
Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaquesAdrian B McDermott, David H O'Connor, Sarah Fuenger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2015
H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin StemAdam K Wheatley, James R R Whittle, Daniel Lingwood, et al.
Medrxiv : the Preprint Server for Health Sciences|January 14, 2021
Fever, Diarrhea, and Severe Disease Correlate with High Persistent Antibody Levels against SARS-CoV-2Maya F Amjadi, Sarah E O'Connell, Tammy Armbrust, et al.
Immunity|March 1, 2025
Early influenza virus exposure shapes the B cell response to influenza vaccination in individuals 50 years laterAbby Spangler, Geoffrey D Shimberg, Grace E Mantus, et al.
Frontiers in Immunology|June 14, 2024
Anti-idiotype isolation of a broad and potent influenza A virus-neutralizing human antibodyAdam S Olia, Madhu Prabhakaran, Darcy R Harris, et al.
Pageof 18